Delivery Order SPE2DE24D0013-SPE2D625F0PEG
- Not listed
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded Cepheid Inc. a delivery order valued at $22,240 on September 9, 2025, for molecular diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV). This firm fixed-price delivery order, which has no set-aside designation, is scheduled for completion by September 16, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. Cepheid is a for-profit...
- The U.S. Defense Department's Medical Supply Chain organization awarded a $2,835 firm fixed-price delivery order to Cepheid Inc. on August 29, 2025, for molecular diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The delivery order, which extends through September 8, 2025, will be performed at Cepheid's facility in Sunnyvale, California. This award carries no small business set-aside designation and represents a continuation of...
- The Defense Logistics Agency awarded a $40.8K delivery order (Contract 4569470191) to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, for the supply of COVID-19/Flu/RSV testing solutions. This firm fixed-price delivery order, with an ultimate completion date of September 23, 2025, carries no set-aside designation and represents part of Cepheid's broader supply relationship with the Defense Department's medical supply chain operations. Cepheid specializes in...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $40,800 by the Defense Department's Medical Supply Chain on August 14, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is for COVID-19, Influenza, and Respiratory Syncytial Virus (RSV) diagnostic testing solutions with an ultimate completion date of August 21, 2025. This award includes no set-aside designation and represents work to be...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a $13,179.30 firm fixed-price delivery order by the Medical Supply Chain (a Defense agency) on May 2, 2025, with completion scheduled for May 9, 2025. The delivery order, designated 4568136320 ! XPCOV2/FLU/RSV-10, is for COVID-19, influenza, and respiratory syncytial virus (RSV) diagnostic testing solutions and carries no set-aside designation. The work will be performed in Sunnyvale,...
- The U.S. Defense Logistics Agency awarded a firm fixed-price delivery order valued at $4,080 to Cepheid Inc. for COVID-19, influenza, and respiratory syncytial virus (RSV) diagnostic solutions. The delivery order, issued on August 22, 2025, with completion targeted for August 29, 2025, represents a continuation of the Medical Supply Chain's procurement of molecular diagnostic testing capabilities. Cepheid, a Sunnyvale, California-based manufacturer specializing in advanced diagnostic systems and...
- The U.S. Defense Department's Medical Supply Chain awarded an $8,160 firm fixed-price delivery order to Cepheid Inc. on August 8, 2025, for molecular diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The delivery order, which carries an ultimate completion date of August 15, 2025, will be performed in Sunnyvale, California, where Cepheid maintains its headquarters. This award represents no set-aside designation and reflects the...
- The Defense Logistics Agency's Medical Supply Chain has awarded a $7,904 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, designated XPCOV2/FLU/RSV-10, represents procurement of diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The contract was awarded on September 8, 2025, with an ultimate completion date of September 15, 2025, and carries no...
- The Defense Logistics Agency awarded a $4,080 firm fixed-price delivery order to Cepheid Inc. on June 6, 2025, for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The order is scheduled for completion by June 13, 2025, with performance occurring at Cepheid's facility in Sunnyvale, California. This delivery order carries no set-aside designation and represents a discrete procurement under the company's existing contract vehicles with...
- The U.S. Defense Logistics Agency awarded a $29,478.60 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on August 6, 2025, with an ultimate completion date of August 13, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The contract carries no set-aside designation and represents a relatively modest...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F0PEGDelivery Order
The Defense Logistics Agency awarded a $12,240 firm fixed-price delivery order to Cepheid Inc. for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract, with an ultimate completion date of August 15, 2025, was awarded on August 8, 2025, with no set-aside designation. Cepheid, a Sunnyvale, California-based manufacturer specializing in molecular diagnostic systems and test kits, will perform the work at its California facility. This delivery order represents a continuation of Cepheid's established relationship with federal health agencies to provide advanced diagnostic capabilities for infectious disease detection. This delivery order likely derives from one of Cepheid's two significant Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs, including a single-award IDV valued at $32.8 million through September 30, 2030, that provides molecular diagnostic testing system reagents and assays. Cepheid's core offerings under similar federal contracts include GeneXpert diagnostic systems, reagents, test kits, and maintenance services designed to detect infectious diseases across multiple federal healthcare systems. The company has demonstrated sustained capability in supporting Department of Defense and Veterans Health Administration diagnostic testing requirements, with contract values historically ranging from thousands to nearly $1 million across various federal networks and agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.2k | 8/8/25 |